Press Releases

STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Important events July - SeptemberNeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study NeuroSTAT receives Fast Track designation from the US Food and Drug Administration.Financial information third quarter (July-Sep

STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Biovica, active in cancer biomarkers, today announced that clinical data - demonstrating that DiviTum can be used as a dynamic, non-invasive biomarker for metastatic breast cancer patients treated with endocrine therapy and palbociclib - will be presented at the San Antonio Breast Cancer Symposium, Decemb

CAMBRIDGE, England, Nov. 20, 2019 /PRNewswire/ -- Cambridge Quantum Computing ("CQC") today announced an important breakthrough in quantum chemistry that will enhance and accelerate the commercialisation of quantum computing in an essential area of human endeavour - the search for new materials in sectors such as energy and pharmaceuticals.Accurately simulating ho

DARMSTADT, Germany, Nov. 20, 2019 /PRNewswire/ -- Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) for its investigational therapy tepotinib* for patients with non-small cell lung cancer (

TSUKUBA, Japan, Nov. 20, 2019 /PRNewswire/ -- The International Center for Materials Nanoarchitectonics (WPI-MANA), a unit of the National Institute for Materials Science (NIMS), had a visit from Prof. Allan S. Hoffman from the University of Washington, a pioneer in smart polymers and biomaterials research,

SUZHOU, China, Nov. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the first patient has been dosed in the Phase I bridging registrational study of ivosidenib (TIBSOVO®) in China. This stand-alone trial is designed to validate the efficacy, safety, and pharm

STAINES-UPON-THAMES, United Kingdom, Nov. 19, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE:  MNK) today announced (1) the early results of the previously announced offers by its wholly owned subsidiaries, Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC (the "Issuers") to Eligible Holders (as defined below) to exchange (the "Exchange Offers") cert

LOS ANGELES, Nov. 19, 2019 /PRNewswire/ -- Wing-Kwai Chung, an accomplished retired structural engineer whose late wife Alice Lee-Tsing Chung was a clinical laboratory scientist in the UCLA blood bank for more than a decade, has made several gifts totaling more than $1 million t

DALLAS, Nov. 19, 2019 /PRNewswire/ -- HealthMine's COO, Amy Lung, a nationally-recognized expert on member driven quality improvement strategies, will be conducting an AHIP Webinar on November 21, 2019, 2-3pm eastern time. The title of the webinar is "Continuous Health Acti

WHITEFISH, Mont., Nov. 19, 2019 /PRNewswire/ -- xD Bio Inc., a privately held, Montana-based company announced today that the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has awarded the company $149,959 over 6 months for the first phase of a Small Busines